Status:
COMPLETED
Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients
Lead Sponsor:
Ain Shams University
Conditions:
Non-Alcoholic Fatty Liver Disease
Eligibility:
All Genders
Brief Summary
This study was designed to assess the relation between serum ferritin and hepatic fibrosis in patients with NAFLD. It included 83 patients with NAFLD with or without hepatic fibrosis, in addition to 3...
Detailed Description
Background: many studies have found a relationship between hepatic iron, serum ferritin and NAFLD or its progress. Aim of the work: is to assess the value of serum ferritin as a non-invasive marker in...
Eligibility Criteria
Inclusion
- adult patients with NAFLD with or without hepatic fibrosis
Exclusion
- Significant alcohol consumption, other causes of liver disease such as viral hepatitis, schistosomiasis, autoimmune, hereditary, drug induced, or decompensated liver cirrhosis.
Key Trial Info
Start Date :
June 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT03250572
Start Date
June 1 2015
End Date
November 1 2016
Last Update
August 15 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.